A Hebrew SeniorLife study published in the Journal of the American Geriatrics Society provides a framework to better understand risk factors for developing delirium, a common psychiatric syndrome… read more.
The haze that blurs a blue sky or a beautiful skyline is caused by tiny particles called PM2.5. PM2.5 describes particulate matter, often made from pollution, less than 2.5… read more.
For decades, researchers have studied the impact of alcohol on cardiovascular health, often with mixed results. Scientists at Monash University in Australia set out to answer the question… read more.
Chest discomfort associated with a heart attack or heart event may often be felt beyond the chest, with many people reporting pain in their shoulders, arms, jaw, neck, back and… read more.
Researchers have long known that air pollution can increase the risk of disorders such as obesity, diabetes, and fertility, but they did not know the exact mechanism for… read more.
Meditating just once proves to make a difference Michigan State University If you are forgetful or make mistakes when in a hurry, a new study from Michigan State… read more.
As high blood pressure puts you at high risk of having a heart attack or stroke (cardiovascular disease), it’s important to keep track of your blood pressure. People… read more.
Researchers report that, for treatment of afebrile (non-feverish) men with a urinary tract infection (UTI), a 7-day course of ciprofloxacin or trimethoprim/sulfamethoxazole is a non-inferior alternative to a… read more.
Gilead Sciences, Inc. announced a pooled analysis of a 48-week open-label extension of two Phase III studies (Study 1489 and Study 1490) shows 99% of participants who initiated… read more.
The study, published June 29 in the Journal of the American Heart Association, provides the strongest evidence yet that the ultra-time-efficient maneuver known as High-Resistance Inspiratory Muscle Strength… read more.
Those who had both the poorest sleep quality and who exercised the least were most at risk of death from heart disease, stroke, and cancer, the findings indicate,… read more.
Takeda Pharmaceutical announced results from two final analyses from the Phase III HELP (Hereditary Angioedema Long-term Prophylaxis) Study Open-label Extension (OLE), which evaluated the long-term safety (primary endpoint)… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
